Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Mar 31, 2017 · 10-K · 90 days after period end · 0001564590-17-005738
| Metric | Q4 2016 | Q4 2015 |
|---|---|---|
| Revenue | $8.77M | $8.29M |
| Net Income | -$14.95M | -$17.90M |
| EPS Diluted | -$0.74 | -$0.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 31, 2017 · 90 d after period end
